Skip to main content
. 2017 Jun 15;4:57–63. doi: 10.1016/j.ctro.2017.04.002

Fig. 2.

Fig. 2

Population based 18F-FDG uptake (in terms of SUV) in the lung versus percentage dose at pre-, mid-, and post-therapy across patients separated into a) RT group and b) RT + erlotinib group. The solid lines correspond to first order linear regressions.